Kirkland & Ellis is advising H.I.G. Capital and its portfolio company, Aspire Pharma, on the acquisition of Morningside Pharmaceuticals. Morningside Pharmaceuticals is a manufacturer, wholesaler, distributor and supplier of generic and branded medicines and healthcare products to the UK and international export markets.
The Kirkland team was led by corporate partners Roger Johnson, Tom McCarthy and Adrian Duncan; debt finance partners Neel Sachdev and Leon Daoud; technology & IP transactions partner John Patten; tax partner Timothy Lowe; and antitrust partner Sally Evans.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
